Search Login Register
Dwarfism
Summary
680
relevant articles (8 outcomes,
25 trials/studies)
found for this Disease
Description:
A genetic or pathological condition that is characterized by short stature and undersize. Abnormal skeletal growth usually results in an adult who is significantly below the average height.
Also Known As:
Nanism
Key Drugs and Agents for Dwarfism
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
Hormones
:
2 outcomes 2 studies in 51 results
: IBA
-
Proteins (Proteins, Gene)
:
2 outcomes in 4 results
: IBA
-
Insulin-Like Growth Factor I (IGF-1)
:
1 outcome 4 studies in 45 results
: IBA
-
Human Growth Hormone (Saizen)
:
1 outcome 4 studies in 44 results
:
FDA 15
Generic
-
Somatotropin Receptors (Growth Hormone Receptor)
:
1 outcome in 11 results
: IBA
-
Diazoxide (Hyperstat)
:
1 outcome in 1 result
:
FDA 5
-
Capsules
:
1 outcome in 1 result
: IBA
-
alginic acid (sodium alginate)
:
1 outcome in 1 result
: IBA
-
Growth Hormone (Somatotropin)
:
7 studies in 151 results
: IBA
-
Somatomedins (Somatomedin)
:
2 studies in 19 results
: IBA
Show All >>
Diseases Related to Dwarfism
-
Lysosomal Storage Diseases (Lysosomal Storage Disease)
-
Hypoglycemia (Reactive Hypoglycemia)
-
Neoplasms (Cancer)
-
Hemophilia A (Haemophilia)
-
Nervous System Diseases (Neurological Disorders)
Show All >>
Key Therapies for Dwarfism
Efficacy Chart >>
-
Hip Replacement Arthroplasty (Total Hip Replacement)
:
1 outcome in 1 result
-
Transplants (Transplant)
:
1 study in 2 results
-
Arthroplasty
:
4 results
-
Cesarean Section (Caesarean Section)
:
3 results
-
Caloric Restriction
:
2 results
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.